NEW YORK, Nov. 29 - Pyrosequencing said Thursday it sold one of its PSQ 96 Systems to the German Armed Forces, which will use the genotyping system to decode and detecting the bacteria and viruses used in biological weapons and diseases such as anthrax and smallpox.
“The very possibility of biological warfare necessitates a rapid, accurate way to detect and type any suspicious agent such as Bacillus anthracis , the causative agent for anthrax,” the head of Germany’s Molecular Genetics Detection Group, a unit of Germany’s Armed Forces Scientific Institute for Protection Technologies, said in a statement.
The detection group said it has developed a method for identifying anthrax using Pyrosequencing’s system.
Pyrosequencing said several research institutions were using its system to develop diagnostic tests for the detection and identification of harmful bacteria and for resistance to commonly used antibiotics.
Pyrosequencing has also offered to provide its technology to the US government to assist in the identification and characterization of harmful pathogens.
In July, Pyrosequencing announced a collaboration with Uppsala University in Sweden to investigate several applications of Pyrosequencing technology for use in the identification of bacteria. The initial focus of the agreement includes Helicobacter pylori , Mycobacterium tuberculosis, and Bacillus anthracis.
The PSQ 96 sells at a list price of $90,000, including software, the detection unit, and a start up kit of consumables.